Bladder dysfunction and management in multiple sclerosis

Mayo Clinic Proceedings

Volumn 72, Issue 12, 1997, Pages 1176-1183

  Andrews, Karen L ^a,b   Husmann, Douglas A ^a  

^a Department of Physical Medicine and Rehabilitation ^*  (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETHANECHOL; DESMOPRESSIN ACETATE; IMIPRAMINE;

CONFERENCE PAPER; DEMYELINATING DISEASE; HUMAN; INTERMITTENT CATHETERIZATION; MICTURITION CYSTOURETHROGRAPHY; MICTURITION DISORDER; MULTIPLE SCLEROSIS; NEUROGENIC BLADDER; NEUROLOGIC EXAMINATION; URINE INCONTINENCE;

EID: 0030668772     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.12.1176     Document Type: Conference Paper

References (31)

1. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien P, Kurland L. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology 1994;44:28-33
2. Blaivas JG, Holland NJ, Giesser B, LaRocca N, Madonna M, Scheinberg L. Multiple sclerosis bladder: studies and care. Ann N Y Acad Sei 1984;436:328-346
3. Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56:245250
4. Chancellor MB, Blaivas JG. Urological and sexual problems in multiple sclerosis. Clin Neurosci 1994;2:189-195
5. Gonor SE, Carroll DJ, Metcalfe JB. Vesical dysfunction in multiple sclerosis. Urology 1985;25:429-431
6. DeLisa JA, Miller RM, Mikulic MA, Hammond MC. Multiple sclerosis. Part II. Common functional problems and rehabilitation. Am Fam Physician 1985 Nov;32:127-132
7. Fowler CJ, van Kerrebroeck PEV, Nordenbo A, Van Poppel H. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis: report from the Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis). J Neurol Neurosurg Psychiatry 1992;55:986-989
8. Miller H, Simpson ÇA, Yeates WK. Bladder dysfunction in multiple sclerosis. BMJ 1965:1:1265-1269
9. Goldstein I, Siroky MB, Sax DS, Krane RJ. Neurourologic abnormalities in multiple sclerosis. J Urol 1982:128:541545
10. Oppenheimer DR. The cervical cord in multiple sclerosis. Neuropathol Appl Neurobiol 1978;4:151-162
11. Wheeler JS Jr, Siroky MB, Pavlakis AJ, Goldstein I, Krane RJ. The changing neurourologic pattern of multiple sclerosis. JUrol 1983:130:1123-1126
12. Linsenmeyer TA, Stone JM. Neurogenic bladder and bowel dysfunction. In: DeLisa JA, Gans BM, editors. Rehabilitation Medicine: Principles and Practice. 2nd ed. Philadelphia: Lippincott; 1993. pp 733-762
13. Blaivas JG, Bhimani G, Labib KB. Vesicourethral dysfunction in multiple sclerosis. JUrol 1979:122:342-347
14. Katz GP, Blaivas JG. A diagnostic dilemma: when urodynamic findings differ from the clinical impression. J Urol 1983:129:1170-1174
15. Kuhlemeier KV, McEachran AB, Lloyd LK, Stover SL, Fine PR. Serum creatinine as an indicator of renal function after spinal cord injury. Arch Phys Med Rehabil 1984;65:694-697
16. Resnick NM, Yalla SV. Management of urinary incontinence in the elderly. N Engl J Med 1985;313:800-805
17. Sirls LT, Zimmern PE, Leach GE. Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol 1994; 151:946-950
18. Kasabian NG, Krause I, Brown WE, Khan Z, Nagler HM. Fate of the upper urinary tract in multiple sclerosis. Neurourol Urodyn 1995;14:81-85
19. Franz DA, Towler MA, Edlich RF, Steers WD. Functional urinary outlet obstruction causing urosepsis in a male multiple sclerosis patient. JEmergMed 1992:10:281-284
20. Andrews KL, Opitz JL. Bladder retraining. In: Sinaki M, editor. Basic Clinical Rehabilitation Medicine. 2nd ed. St. Louis: Mosby; 1993. pp 195-206
21. Kinn AC, Larsson PO. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol 1990; 24:109-112
22. Valiquette G, Herbert J, Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis: a double-blind, crossover trial. Arch Neurol 1996; 53:1270-1275
23. Finkbeiner AE. Is bethanechol chloride clinically effective in promoting bladder emptying? A literature review. J Urol 1985; 134:443-449
24. BarbaliasGA, Klauber GT, BlaivasJG. Critical evaluation of the Credé maneuver: a urodynamic study of 207 patients. J Urol 1983; 130:720-723
25. Reinberg Y, Fleming T, Gonzalez R. Renal rupture after the Credé maneuver. J Pediatr 1994; 124:279-281
26. Madersbacher H. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts. Paraplegia 1990;28:217-229
27. Lockhart JL, Bejany D, Politano VA. Augmentation cystoplasty in the management of neurogenic bladder disease and urinary incontinence. J Urol 1986;135:969-971
28. Kaplan SA, Blaivas JG. Voiding dysfunction in patients with multiple sclerosis. J Enterostomal Ther 1990;17:120129
29. Eckford SB, Kohler-Ockmore J, Feneley RCL. Long-term follow-up of transvaginal urethral closure and suprapubic cystostomy for urinary incontinence in women with multiple sclerosis. BrJUrol 1994;74:319-321
30. Kaufman JM, Fam B, Jacobs SC, Gabilondo F, Yalla S. Kane JP, et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 1977;! 18:967-971
31. McGuire EJ, Savastano JA. Urodynamic findings and longterm outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction. J Urol 1984; 132:713-715